Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 26, 2005
Phospholipid hydrolysis in a pharmaceutical emulsion assessed by physicochemical parameters and a new analytical methodLaura Rabinovich-Guilatt, Catherine Dubernet, Karen Gaudin, et al.
Bioconjugate Chemistry|September 16, 2004
Specific antitumor targetable beta-cyclodextrin-poly(ethylene glycol)-folic acid drug delivery bioconjugateStefano Salmaso, Alessandra Semenzato, Paolo Caliceti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 20, 2007
A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia typesL Harivardhan Reddy, Catherine Dubernet, Sinda Lepetre Mouelhi, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 9, 2008
Preclinical toxicology (subacute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicineL Harivardhan Reddy, Pierre-Emmanuel Marque, Catherine Dubernet, et al.
International Journal of Pharmaceutics|September 22, 2010
PEGylation and preliminary biocompatibility evaluation of magnetite-silica nanocomposites obtained by high energy ball millingMartina Pilloni, Julien Nicolas, Véronique Marsaud, et al.
Anti-Cancer Drugs|October 2, 2008
Squalenoyl nanomedicine of gemcitabine is more potent after oral administration in leukemia-bearing rats: study of mechanismsLakkireddy Harivardhan Reddy, Humberto Ferreira, Catherine Dubernet, et al.
Journal of Biomedical Nanotechnology|August 27, 2010
Folic acid-targeted mesoporous silica nanoparticles for two-photon fluorescenceValérie Lebret, Laurence Raehm, Jean-Olivier Durand, et al.
Medecine Sciences : M/S|September 22, 2009
[Mesoporous silica nanoparticles for two-photon fluorescence]Valérie Lebret, Laurence Raehm, Jean-Olivier Durand, et al.
Pageof 3